EpiGentek Investor

Biotechnology investments.


Invests into

Headquarters: New York, United States
Founded Date: 2005
Investor Type: N/A
Investment Stage: N/A
Total Funding: N/A
Technology: Immunotherapy
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Industry: PharmTech